Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

2.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.4K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.3K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virtual Responsive Neurostimulation Implantation: From Intracranial Connectivity to Optimized Lead Placement.

medRxiv : the preprint server for health sciences·2026
Same author

Postapproval Study for Brain-Responsive Neurostimulation for Drug-Resistant Focal Epilepsy: Three-Year Efficacy and Interim Safety Results.

Neurology·2026
Same author

A guide to neuromodulation in drug-resistant epilepsy.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Thalamic connectivity mirrors spatial maps of network dysfunction in nonlesional focal epilepsy.

Epilepsia·2026
Same author

Eye movements reflect memory-related theta activity in the human brain.

PLoS biology·2026
Same author

Timing is everything: Expert opinion on researching epilepsy rhythms by the ILAE Task Force on Chronobiology.

Epilepsia·2026

Related Experiment Video

Updated: Apr 16, 2026

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

11.5K

Clinical approach to posttraumatic epilepsy.

Vikram R Rao1, Karen L Parko1

  • 1Department of Neurology, University of California, San Francisco, California.

Seminars in Neurology
|February 26, 2015
PubMed
Summary
This summary is machine-generated.

Traumatic brain injury (TBI) can lead to posttraumatic epilepsy (PTE), a condition with delayed seizures. Early risk assessment and diverse treatments, including neuromodulation, are crucial for managing PTE.

More Related Videos

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

26.6K
Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
07:58

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

Published on: September 15, 2011

9.9K

Related Experiment Videos

Last Updated: Apr 16, 2026

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

11.5K
Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

26.6K
Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
07:58

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

Published on: September 15, 2011

9.9K

Area of Science:

  • Neurology
  • Neuroscience
  • Epileptology

Background:

  • Traumatic brain injury (TBI) is a leading cause of acquired epilepsy.
  • Posttraumatic epilepsy (PTE) causes significant morbidity and can have a long latency period after injury.
  • Identifying biomarkers and preventative therapies for epileptogenesis is critical due to the silent period in PTE.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and treatment of posttraumatic epilepsy (PTE).
  • To provide a roadmap for clinicians managing patients with PTE.
  • To highlight emerging therapeutic strategies for refractory PTE.

Main Methods:

  • Literature review of epidemiology, diagnostic considerations, and treatment options for PTE.
  • Discussion of risk stratification using molecular and radiographic biomarkers.
  • Overview of current and emerging therapies, including pharmacological, surgical, and neuromodulation approaches.

Main Results:

  • PTE risk is associated with TBI severity, with a potential decades-long latency to seizures.
  • Clinical management necessitates vigilant neurologic surveillance and recognition of diverse PTE endophenotypes.
  • An expanding array of treatments exists, with neuromodulation showing promise for refractory cases.

Conclusions:

  • Effective management of PTE requires understanding its epidemiology and varied presentation.
  • Risk stratification and timely intervention are key to improving outcomes for TBI survivors at risk of PTE.
  • Neuromodulation represents a significant advancement in treating refractory posttraumatic epilepsy.